在日本牙科中普及细胞治疗的挑战和前景
1Medical Technology Innovation Center, Juntendo University, Tokyo, Japan.
Journal of oral biosciences
|November 22, 2025
概括
在日本的牙科诊所中,介质干细胞 (MSC) 疗法用于组织再生,但其广泛采用面临挑战. 提高安全性,有效性验证和临床数据收集对于推进牙科再生医学至关重要.
科学领域:
- 牙科再生医学 牙科再生医学
- 细胞疗法是一种细胞疗法.
- 组织工程是组织工程.
背景情况:
- 再生医学,特别是介质干细胞 (MSC) 疗法,在日本牙科中显示出显著的潜力.
- 尽管人们对MSC日益感兴趣,并有一些临床应用,但MSC治疗在牙科实践中的应用仍然有限.
- 这项研究调查了日本牙科中细胞治疗的现状,并确定了其更广泛实施的障碍.
研究的目的:
- 报告日本牙科细胞治疗的现状.
- 讨论阻碍细胞治疗在牙科实践中普及的挑战.
- 概述牙科再生医学的未来方向.
主要方法:
- 审查使用细胞治疗的日本牙科诊所当前的做法.
- 分析与MSC治疗的安全性,疗效和数据收集相关的挑战.
- 探索扩大牙科再生医学的潜在策略.
主要成果:
- 截至2025年5月,日本约有50家私人牙科诊所为口腔组织再生提供基于MSC的疗法,其中大多数外包细胞处理.
- 牙纸是MSC的主要来源,其次是脂肪组织和骨髓.
- 关键的挑战包括在临床使用之前对特定条件的安全性和疗效的验证不足以及缺乏系统的临床数据收集.
结论:
- 加强对牙科诊所的支持对于再生医学的安全扩张至关重要.
- 牙科实践与学术机构之间需要更加密切的合作.
- 系统地收集临床数据对于确保牙科细胞疗法的安全性和有效性至关重要.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...


